Haemonetics Corp. (HAE) Posts Q2 EPS of $0.69, Tops by 4c
HAE Hot Sheet
Revenue Growth %: +9.8%Financial Fact:
Income before provision for income taxes: 21.33M
Today's EPS Names:
TARO, BRLI, TLB, More
Haemonetics Corp. (NYSE: HAE) reports Q2 EPS of $0.69, 4 cents better than the analyst estimate of $0.65. Revenue for the quarter was $157.07 million, which compares to the estimate of $157.84 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- UPDATE: NetApp, Inc. (NTAP) Tops Q4 EPS by 3c; Guides Q1 Lower
- Tiffany & Co. (TIF) Misses Q1 EPS Views; Lowers FY12 EPS, Revs Growth Outlook
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
